CN114703228B - Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model - Google Patents
Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model Download PDFInfo
- Publication number
- CN114703228B CN114703228B CN202210261147.0A CN202210261147A CN114703228B CN 114703228 B CN114703228 B CN 114703228B CN 202210261147 A CN202210261147 A CN 202210261147A CN 114703228 B CN114703228 B CN 114703228B
- Authority
- CN
- China
- Prior art keywords
- epc2
- epc1
- mutant
- zebra fish
- environment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000252212 Danio rerio Species 0.000 title claims abstract description 46
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 101150047068 Epc2 gene Proteins 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000012224 gene deletion Methods 0.000 claims abstract description 5
- 241000251468 Actinopterygii Species 0.000 claims description 27
- 241000607528 Aeromonas hydrophila Species 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 108091033409 CRISPR Proteins 0.000 claims description 10
- 206010021143 Hypoxia Diseases 0.000 claims description 9
- 230000007954 hypoxia Effects 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 5
- 230000007613 environmental effect Effects 0.000 claims description 5
- 108020005004 Guide RNA Proteins 0.000 claims description 4
- 238000010354 CRISPR gene editing Methods 0.000 claims description 3
- 238000010362 genome editing Methods 0.000 claims description 3
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 241000283070 Equus zebra Species 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 37
- 238000012544 monitoring process Methods 0.000 abstract description 20
- 229910052760 oxygen Inorganic materials 0.000 abstract description 13
- 239000001301 oxygen Substances 0.000 abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000003651 drinking water Substances 0.000 abstract description 3
- 235000020188 drinking water Nutrition 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 238000003894 drinking water pollution Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000001514 detection method Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 238000012163 sequencing technique Methods 0.000 description 10
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000034994 death Effects 0.000 description 6
- 231100000517 death Toxicity 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000000366 juvenile effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 102100031948 Enhancer of polycomb homolog 1 Human genes 0.000 description 5
- 101710186942 Enhancer of polycomb homolog 1 Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 210000001161 mammalian embryo Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000003344 environmental pollutant Substances 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 3
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 3
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 3
- 102100031941 Enhancer of polycomb homolog 2 Human genes 0.000 description 3
- 101710186833 Enhancer of polycomb homolog 2 Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 101150075015 cox-17 gene Proteins 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 210000003470 mitochondria Anatomy 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010042291 Serum Response Factor Proteins 0.000 description 2
- 102100029504 Zinc finger protein RFP Human genes 0.000 description 2
- 101710110903 Zinc finger protein RFP Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 102000037983 regulatory factors Human genes 0.000 description 2
- 108091008025 regulatory factors Proteins 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241001247197 Cephalocarida Species 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 241000238571 Cladocera Species 0.000 description 1
- 108091004554 Copper Transport Proteins Proteins 0.000 description 1
- 102000037773 Copper transporters Human genes 0.000 description 1
- 108091006566 Copper transporters Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102100036035 Cytochrome c oxidase copper chaperone Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101150060346 EPL1 gene Proteins 0.000 description 1
- 108010043945 Ephrin-A1 Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010048671 Homeodomain Proteins Proteins 0.000 description 1
- 102000009331 Homeodomain Proteins Human genes 0.000 description 1
- 101000875933 Homo sapiens Cytochrome c oxidase copper chaperone Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 101100221725 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-17 gene Proteins 0.000 description 1
- 102000004446 Serum Response Factor Human genes 0.000 description 1
- 102100022056 Serum response factor Human genes 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 101150038500 cas9 gene Proteins 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 108700024526 zebrafish sox32 Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of molecular biology, in particular to a method for preparing a polypeptideepc1 ‑/‑ epc2 ‑/‑ Mutant and application thereof in construction of environment-susceptible zebra fish model, and construction of mutant and application of mutant in construction of environment-susceptible zebra fish modelepc1Andepc2the homozygous mutant zebra fish with single gene deletion is hybridized to obtain the homozygous double mutantepc1 ‑/‑ epc2 ‑/‑ Zebra fish. Obtained by the inventionepc1 ‑/‑ epc2 ‑/‑ The environment-susceptible mutant zebra fish model can be used for biological indication and monitoring of oxygen content and bacteria in a fishery water environment or a drinking water environment, is applied to real-time early warning of water environment pollution and drinking water pollution, and has the advantages of higher sensitivity, quicker emergency effect and the like.
Description
Technical Field
The invention belongs to the field of molecular biology, and in particular relates to epc1 -/- epc2 -/- Mutant and application thereof in construction of environment-susceptible zebra fish model, epc1 constructed by the invention -/- epc2 -/- The environment-susceptible mutant zebra fish can be used for establishing a water environment monitoring system taking organism death as a monitoring endpoint.
Background
EPC1 (enhancer of polycomb homolog 1) and EPC2 (enhancer of polycomb homolog 2) are important chromatin regulatory factors that are highly conserved from yeast to human (Doyon et al, 2004). EPC family genes are involved in a variety of physiological processes including cell differentiation and development (Prasad et al 2014,Wang et al 2016,Searle et al 2017). In yeast, the deletion of Epl1 (yeast homolog of EPC) leads to the accumulation of cells at G2/M and the global deletion of acetylated histones H4 and H2A, epl1 mutations inhibiting gene silencing by telomere position effects (Boud reault et al 2003). In mammals, most reports on genes of the EPC family have focused on their function in skeletal muscle differentiation (Kim et al 2009,Kee et al 2012). EPC1 is essential for initiating skeletal muscle differentiation in mice and can interact with HOP proteins (Homeodomain Only), serum response factors (serum response factor, SRF) or RET finger proteins (RET finger protein, RFP) to induce expression of the relevant genes (Kee et al 2007,Kim et al 2009). EPC genes also play an important role in tumorigenesis, EPC1 genes are located on human chromosome 10p11, a region where genomic rearrangements are frequent in various human tumors, and the formation of fusion genes (such as EPC1-PHF1, EPC1-ASXL2, etc.) can lead to the generation of a range of tumor-related diseases. EPC1 and EPC2 are also required to maintain the stem cell potential of acute myeloid leukemia (acute myeloid leukemia, AML). In zebra fish, little research is done on epc1 and epc2 genes, and the only literature reported to date is that preliminary screening results published in the university of harvard Zon laboratory at 2013 for function against 425 apparent regulatory factors showed that epc2 gene knockdown affected zebra fish initial erythrocyte development (Huang et al, 2013).
Cox17 (cytochrome c oxidase copper chaperone COX 17) is an important component of cytochrome oxidase, and is involved in the precise structural formation of the mitochondrial cristae, and also acts as an important copper transporter in mitochondria to carry Cu + Cytochrome oxidase transported to mitochondria, thereby regulating copper metallization of cytochrome oxidase and regulating distribution and content of copper in mitochondria.
In a fishery water environment, the occurrence of fish diseases is closely related to pathogenic bacterial infection in a culture environment, for example, aeromonas hydrophila can enter blood through fish body skin, then enter liver, kidney, spleen and other tissues through blood circulation, infect an immune system, and finally generate systemic bleeding symptoms. In addition, bacterial contamination in drinking water environments also threatens human health. Dissolved Oxygen (DO) in a water body is comprehensively influenced by factors such as partial pressure of Oxygen in air, water temperature, contact area of liquid level and Oxygen in air, day and night change, oxygen consumption sediment, water flow speed, salinity, depth of water, photosynthesis rate of aquatic plants and algae, respiration intensity of aquatic organisms and the like. Moreover, when a large amount of industrial wastewater or domestic sewage enters a water body, serious deoxidation of the water body is caused, so that the dissolved oxygen is generally used as a main index of environment monitoring and self-cleaning capability of the water body. Oxygen is critical to the survival of aerobic organisms, particularly freshwater fish, which are more susceptible to hypoxia stress.
In water environment monitoring, the application of biological monitoring technology is becoming more and more widespread. The biological monitoring is based on the corresponding change of indexes such as physiological and biochemical indexes, protein molecules and the like of each level of organisms in an ecological system after environmental pollution is utilized, and comprehensively reflects the environmental pollution problem, the ecological influence effect and the like. Compared with the traditional single physical and chemical detection, the biological monitoring can show the effect of environmental pollutants through individuals, comprehensively reflect the complex influence of various pollutants, has the advantages of rapidness, broad spectrum, comprehensiveness and the like, can early and timely early warn in water quality pollution such as sudden pollution accidents and the like, and can carry out rapid qualitative analysis on the environmental pollution condition from the perspective of biological response pollutant toxicity. At present, research and application of biological monitoring, indication, diagnosis and technology of water environment have become research hot spots and leading edge fields in the field of environmental evaluation and protection.
The fish starts to be used in a biological monitoring and early warning system in 1929, and the water environment is monitored by using the bearing according to the respiratory change of the fish. The swimming behavior, positive fluidity, selective behavior and the like of the fish are sequentially applied to water environment monitoring. Biological monitoring was applied to the environment as early as the 40 s of the 20 th century in developed countries such as europe and america. Such as french research and development of water quality monitoring systems that utilize fish as a test organism; the biological water quality monitoring system based on video image understanding is developed by BBE company in Germany, and achieves the aim of water quality evaluation through analysis and understanding of biological state change by the principle that behavior and distribution habits of water fleas and fishes are influenced by water quality; the water quality monitoring system based on visual image understanding of fish as a test organism is also being researched and developed by the emerging company in japan. In addition, the European International Commission on ocean exploration (ICES) has used biomarkers as important indicators for the assessment of marine ecological health that indicate heavy metal contamination. European scholars such as france and the united kingdom propose to jointly indicate ocean pollution levels by using synchronous responses of multiple biomarkers, and establish multiple comprehensive indexes for diagnosing sea pollution characteristics on the basis of comprehensive statistical marker response information. The research and system construction of the environmental biological monitoring in China are started later, the biological monitoring technology is gradually introduced in the 80 s of the 20 th century, and the monitoring system needs to be further enhanced and perfected.
Disclosure of Invention
The invention aims to provide epc1 -/- epc2 -/- The application of the mutant in constructing an environment-susceptible zebra fish model. In order to achieve the above object, the present invention adopts the following measures:
epc1 -/- epc2 -/- the application of the mutant in constructing an environment-susceptible zebra fish model comprises the step of double knocking out epc1 (gene ID: 566686) and epc2 (gene ID: 394050) genes in zebra fish by utilizing a conventional mode in the field, and the obtained transgenic fish is sensitive to aeromonas hydrophila and/or oxygen stress and can be used for preparing the environment-susceptible zebra fish model.
In the application, it is preferable that the homozygous mutant zebra fish with single gene deletion of epc1 and epc2 is respectively constructed, and then the homozygous mutant zebra fish and the homozygous mutant zebra fish are hybridized to obtain the homozygous double mutant epc1 -/- epc2 -/- Zebra fish;
in the above application, preferably, the CRISPR/Cas9 gene editing technology adopted for constructing the homozygous mutant zebra fish with single gene deletion is that: 5'-ggtctggcagatcctcgcag-3', epc2gRNA target site is: 5'-gggcgtctagcgctcgcgcg-3'.
Compared with the prior art, the invention has the following advantages:
using epc1 obtained according to the present invention as an important point for environmental detection with respect to death of normal wild-type fish as a monitoring endpoint -/- epc2 -/- The environment-susceptible mutant zebra fish model can be prepared by adjusting the oxygen content and bacteria in the fishery water environment or the drinking water environmentThe biological indication monitoring is carried out, and the method is applied to real-time early warning of water environment pollution and drinking water pollution, and has the advantages of higher sensitivity, quicker emergency effect and the like. In addition, the sensitivity of the model to other environmental stress factors (environmental pollutants) can be detected, and other environmental susceptibility factors of the model can be screened out and applied to water environment detection.
Drawings
FIG. 1 is a schematic diagram of epc1 and epc2 gene mutation targets;
wherein A is an epc1 gene pattern diagram deleted by 11bp, and B is an epc2 gene pattern diagram deleted by 4 bp.
FIG. 2 shows that different concentrations of Aeromonas hydrophila infest control (wild type), epc1 -/- 、epc2 -/- And epc1 -/- epc2 -/- The lethality of the double mutant zebra fish juvenile fish is shown in a schematic diagram;
wherein A-C are each 10 6 CFU/mL、10 7 CFU/mL、10 8 Aeromonas hydrophila at CFU/mL concentration.
FIG. 3 shows the infection of control (wild type) and cox17 by Aeromonas hydrophila at various concentrations -/- The lethality of mutant zebra fish juvenile fish is shown in the schematic diagram;
A. b is respectively 10 6 CFU/mL and 10 7 CFU/mL of Aeromonas hydrophila.
FIG. 4 is 2% hypoxia stress control (wild type), epc1 -/- 、epc2 -/- And epc1 -/- epc2 -/- Survival rate of double mutant zebra fish juvenile fish is shown in the schematic diagram;
A-C is 72hpf wild-type, epc1 under 2% hypoxia stress and 21% normoxic conditions, respectively -/- 、epc2 -/- And epc1 -/- epc2 -/- Survival statistics of young fish within 12 hours after mutant embryo.
Detailed Description
The technical scheme of the invention is a conventional mode in the field unless specifically stated; the reagents or materials used, unless otherwise specified, are commercially available.
Example 1:
obtaining epc1 -/- epc2 -/- The method for transforming the mutant zebra fish into a gene fish line comprises the following steps:
1.1 Experimental materials
Wild zebra fish (Zebrafish, danio rerio) and mutants were both raised in the aquatic university of china, aquacultural houses under the following conditions: the water temperature is 28.5+/-0.5 ℃, the illumination time and the darkness time are respectively 14h and 10h, and the artemia are fed for 2 times per day.
1.2 Experimental methods
Selection and confirmation of the target sites of the epc1 and epc2 genes of zebra fish:
determining epc1gRNA target sites as: 5'-ggtctggcagatcctcgcag-3'.
Determining epc2gRNA target sites as: 5'-gggcgtctagcgctcgcgcg-3'.
1.2.1 construction of epc1 Using CRISPR/Cas9 Gene editing techniques, respectively -/- And epc2 -/- Mutant
1.2.1.1 in vitro synthesis of gRNA
PCR amplification was performed with the pMD19-TgRNA (Chang et al, 2013) plasmid as template, with either the upstream primer (epc1_gRNA-F5'gtaatacgactcactataggtctggcagatcctcgcaggttttagagctagaaatagc 3') or (epc2_gRNA-F5'gtaatacgactcactatagggcgtctagcgctcgcgcggttttagagctagaaatagc 3') with the T7 promoter and specific target site sequence, and the downstream universal primer (gRNA-R5'-aaaagcaccgactcggtgcc-3'). The PCR system is as follows:
the reaction conditions are as follows: pre-denatured at 94℃for 3min,30 cycles (denaturation at 94℃for 30s, annealing at 60℃for 30s, extension at 72℃for 10 s), and extension at 72℃for 5min.
Taking 1 mu L of PCR product to carry out agarose gel electrophoresis detection, purifying and recycling through a PCR clean kit;
in vitro transcription was performed using Thermo Transcript Aid T7 High Yield Transcription Kit, the transcription system is as follows:
mixing, centrifuging, sealing, and incubating in a water bath kettle at 37 ℃ for 2 hours; adding 1 mu L DNase, incubating at 37 ℃ for 15min, and removing the DNA template; 1. Mu.L of EDTA was added and incubated at 60℃for 10min to terminate the reaction; adding 30 mu L of DEPC water and 30 mu L of LiCl, uniformly mixing, and precipitating for 4 hours at-80 ℃; centrifuging at 4deg.C for 10min at 14000 g; the supernatant was discarded, 1mL of 70% ethanol was added for washing, and the mixture was centrifuged at 14000g for 10min at 4 ℃; repeating the previous step; after the supernatant is discarded, the mixture is dried at room temperature, 20 mu L of RNase-free water is added for dissolution, 1 mu L of RNA concentration and quality are measured by a NanoDrop 2000 nucleic acid quantitative instrument, the mixture is diluted to 80 ng/mu L, and the mixture is split-packed and placed at-80 ℃ for standby, thus obtaining epc1_gRNA and epc2_gRNA.
1.2.1.2 Synthesis of Cas9 mRNA
Cas9 mRNA was prepared: linearizing the Cas9 plasmid through single digestion of XbaI, taking 1 mu L of enzyme digestion product to carry out agarose gel electrophoresis to confirm complete linearization, and purifying and recovering the linearization product by using a PCR purification kit;
cas9 mRNA was synthesized by in vitro transcription using the MAXIscript T7 Kit of Ambion, the transcription system being as follows:
mixing the above systems, centrifuging, sealing, and incubating in a water bath at 37deg.C for 2 hr; adding 1 mu L DNase, incubating at 37 ℃ for 15min, and removing the DNA template; 1. Mu.L of EDTA was added and incubated at 60℃for 10min to terminate the reaction; adding 30 mu L of DEPC water and 30 mu L of LiCl, uniformly mixing, and precipitating for 4 hours at-80 ℃; 14000g at 4deg.C for 10min; the supernatant was discarded, 1mL of 70% ethanol was added for washing, at 4 ℃,14000g,10min; repeating the previous step; after discarding the supernatant, air-drying at room temperature, adding 20. Mu.L of RNase-free water for dissolution, taking 1. Mu.L of the solution, measuring the concentration and quality of RNA by using a NanoDrop 2000 nucleic acid quantitative measuring instrument, diluting 500 ng/. Mu.L, subpackaging and then placing the solution at-80 ℃ for standby.
1.2.1.3 F 0 Target point mutation efficiency detection and genetic screening
(1) Uniformly mixing 500 ng/mu L of Cas9 and 80 ng/mu L of gRNA in equal volumes, and microinjection into single-cell-phase zebra fish embryos, wherein at least 200 embryos are injected into each target point, and a part of wild-type embryos in the same batch are reserved as controls for embryo injection;
(2) Taking 20 embryos of injection group and control group respectively, adding 100 mu L of NaOH (50 mM) lysate, cracking for 20min at 95 ℃, adding 10 mu L of Tris-HCl (pH 8.0 50 mM) for balancing, and taking the embryos as a PCR template to be preserved at 4 ℃ for later use;
(3) Using detection primer (epc 1-det-F:5'-tttctcattctccacctcc-3', epc1-det-R:5'-acaaaataaatcccagca-3'; epc2-det-F:5'-tcagagatgcctttaaccgtc-3', epc2-det-R: 5'-gccagtgattcagaagggct-3'), carrying out ordinary PCR amplification using the above product as a template;
(4) Taking 1 mu L of PCR product to carry out agarose gel detection and then sending the PCR product to sequencing;
(5) Identifying an effective target according to a sequencing result, and injecting F corresponding to the effective target in the same batch 0 Embryo culture to adult fish.
(6) Shearing F 0 Adding 50 mu L of NaOH (50 mM) lysate into the tail fin of the adult fish, cracking for 20min at 95 ℃, adding 5 mu L of Tris-HCl (50 mM pH 8.0) for balancing, and taking the mixture as a PCR template to be preserved at 4 ℃ for later use;
(7) Using detection primer, using the above-mentioned product as template to make ordinary PCR amplification;
(8) Taking 1 mu L of PCR product to carry out agarose gel detection and then sending the PCR product to sequencing;
(9) Selection of mutant F based on sequencing results 0 Mating with wild zebra fish, collecting F 1 Taking 20 embryos, adding 100 mu L of NaOH pyrolysis liquid into the 20 embryos, carrying out pyrolysis for 20min at 95 ℃, adding 10 mu L of Tris-HCl for balancing, carrying out ordinary PCR amplification by taking the products as templates, and carrying out sequencing after electrophoresis detection;
(8) Based on sequencing results, mutation heritable F is selected 1 (F 0 Offspring) embryos mated with wild zebra fish and raised to size (at least 60F 1 Adult fish for screening mutant F 1 Adult fish).
1.2.1.4F carrying target site mutations 1 Adult fish screening
(1) Will F 1 Raising the mixture to be large enough (1-2 months), and cutting tail fins;
(2) Adding NaOH lysate, cracking for 20min at 95 ℃, adding 5 mu LTris-HCl for balancing, and taking the mixture as a PCR template for common PCR amplification;
(3) Sequencing after electrophoresis detection, and screening out F with mutation 1 Adult fish;
(4) The residual PCR products are purified and recovered by a PCR purification kit, then are connected to a pM18-T carrier for transformation, single colony is selected for colony PCR amplification, and amplified products are sent to a qingke biological company for sequencing;
(5) According to the sequencing result, 1-2 mutants are selected, each mutant ensures that both the male and the female are matched with the male and the female of the same mutation type, and F is obtained 2 And (3) embryo.
1.2.1.5F carrying target site mutations 2 Adult fish screening
(2) Will F 2 Embryo raising to be large enough, and cutting tail fins;
(2) Adding 50 mu L of NaOH lysate, cracking for 20min at 95 ℃, adding 5 mu L of Tris-HCl for balancing, and taking the mixture as a PCR template for common PCR amplification;
(3) Sequencing after electrophoresis detection, and screening out F with mutation 2 And adult fish can be ensured to be male and female, and can be used for subsequent experiments.
1.2.2epc1 -/- epc2 -/- Obtaining of double mutants
Epc1 is used -/- And epc2 -/- Mating the homozygous mutant zebra fish to obtain heterozygous F 1 epc1 +/- epc2 +/- F is to F 1 Is obtained by male and female mating of F 2 The colony is subjected to DNA electrophoresis detection and DNA sequencing identification by using a screening primer (epc 1-122bp-F4:5'-tgaaaccgctgcccatattc-3', epc1-122bp-R4:5'-at ggtgttccagttcctcgt-3'; epc2-147-F:5'-ccgaatgatccgtgttctgtg-3', epc2-147-R: 5'-gttgatggagacgcagtcgg-3') to obtain the homozygous double mutant epc1 -/- epc2 -/- 。
By the above experiment, we can obtain epc1 capable of stable inheritance -/- epc2 -/- Double mutant. Epc1 compared to wild type (epc 1-targetSEQ ID No.1 and epc 2-targetSEQ ID No. 2) -/- epc2 -/- The target sequences in the double mutants were mutated to the sequences shown in epc 1-variant SEQ ID No.3 and epc 2-variant SEQ ID No.4, respectively, resulting in frame shift mutations. The epc1 gene codes 796 amino acids, 11 base pairs in the 1 st exon are knocked out, and then gene expression is terminated in advance, and only 66 amino acids are coded; the epc2 gene encodes 751 amino acids, and gene expression is terminated in advance after knocking out 4 base pairs in the 1 st exon, and only encodes 10 amino acids (A-B in FIG. 1).
>epc1-target SEQ ID NO.1
ggtctggcagatcctcgcagcgg
>epc2-target SEQ ID NO.2
cggcgtctagcgctcgcgcgcgg
>epc1-mutant SEQ ID NO.3
ggtctgcagcgg
>epc2-mutant SEQ ID NO.4
cggcgtctagcgctcgcgg
Example 2: aeromonas hydrophila stress experiment
(1) Inoculating aeromonas hydrophila with LB medium at the amount of 0.1% v/v, and shaking in a 28 ℃ incubator at 220 r/min;
(2) When the culture is carried out for 8 hours, the concentration of the aeromonas hydrophila liquid reaches a higher level, and the coating flat plate method is used for detecting the concentration of the aeromonas hydrophila at the moment. Diluting Aeromonas hydrophila mother liquor with sterilized deionized water 10 6 Taking 100 mu L of the diluted bacterial liquid, coating LB plates, culturing the three plates in parallel in a 28 ℃ incubator, calculating the number of single bacterial colonies the next day, and taking an average value to obtain the actual concentration of the bacterial liquid;
experimental pathogen Aeromonas hydrophila has an LC50 of 10 for zebra fish 10 CFU/mL
(3) Diluting aeromonas hydrophila with sterilized deionized water, adjusting the concentration of aeromonas hydrophila, and preparing aeromonas hydrophila liquid with different gradient concentrations. In this experiment, 3 aeromonas hydrophila solutions with different concentration gradients were prepared, the concentrations were respectively: 10 8 CFU/mL、10 7 CFU/mL、10 6 CFU/mL. Collecting the wild type, epc1 obtained in example 1 -/- 、epc2 -/- 、epc1 -/- epc2 -/- Double mutant and mutant cox17 -/- Zebra fish embryos (Zhang et al 2020), young zebra fish developed to 68hpf were each rib forced into different concentrations of aeromonas hydrophila fluid, 3 replicates per group, 50 replicates per group.
(4) Counting the death rate of the juvenile zebra fish every 12 or 24 hours;
(5) And (5) finishing the death rate of the young zebra fish, and drawing a line graph.
The results show that: epc1 compared to wild type juvenile fish -/- 、epc2 -/- And epc1 -/- epc2 -/- Mutant pair 10 6 CFU/mL (A in FIG. 2), 10 7 CFU/mL (B in FIG. 2), 10 8 Different concentrations of CFU/mL (C in FIG. 2) were sensitive to aeromonas hydrophila stress, and epc1 -/- epc2 -/- Double mutants are more sensitive than single mutants. cox17 -/- Mutant pair 10 6 CFU/mL (A in FIG. 3), 10 7 The concentration of CFU/mL (B in FIG. 3) was not sensitive to aeromonas hydrophila stress.
Mortality (%) = (number of deaths per repeat/total number of replicates (50)) × 100% per repeat
Average mortality (%) = (mortality of repetition 1 + mortality of repetition 2 + mortality of repetition 3)/3 for each group
Example 3:
hypoxia stress experiment
(1) Regulating the oxygen concentration of the low-oxygen bin to 2%, the nitrogen concentration to 93%, the carbon dioxide concentration to 5% and the temperature to 28.5 ℃;
(2) Putting a proper amount of zebra fish culture circulating water into a hypoxia chamber in advance for 12 hours, and stirring to ensure that the oxygen content of the circulating water is 2%;
(3) Collection of wild-type, mutant (epc 1) -/- 、epc2 -/- And epc1 -/- epc2 -/- ) 72hpf juvenile fish. Each set of 3 replicates of 50 samples each placed at 6Replacing water in the culture dish with water with oxygen content of 2% prepared in the step (2) in a culture dish with 0mm, and then placing the sample in a hypoxia chamber; the same treated fish was used as a control at normal oxygen concentration.
(4) Counting and recording the death number once every two hours;
(5) The statistical data is analyzed and the significance calculated.
Survival per repeat (%) = (number of survival per repeat/total number of replicates (50)) × 100%
Average survival (%) = (survival of repeat 1 + survival of repeat 2 + survival of repeat 3)/3 for each group
The results show that: for young zebra fish of 72hpf, epc2 relative to the 72hpf wild type -/- (FIG. 4B) and epc1 -/- epc2 -/- The hypoxia tolerance of the mutants (C in fig. 4) were significantly down-regulated. And epc1 -/- The mutant had no significant change in hypoxia tolerance (a in fig. 4).
Sequence listing
<110> university of agriculture in China
<120> application of epc1epc2 mutant in construction of environment-susceptible zebra fish model
<160> 17
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
ggtctggcag atcctcgcag cgg 23
<210> 2
<211> 23
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 2
cggcgtctag cgctcgcgcg cgg 23
<210> 3
<211> 12
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 3
ggtctgcagc gg 12
<210> 4
<211> 19
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 4
cggcgtctag cgctcgcgg 19
<210> 5
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
ggtctggcag atcctcgcag 20
<210> 6
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
gggcgtctag cgctcgcgcg 20
<210> 7
<211> 58
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
gtaatacgac tcactatagg tctggcagat cctcgcaggt tttagagcta gaaatagc 58
<210> 8
<211> 58
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
gtaatacgac tcactatagg gcgtctagcg ctcgcgcggt tttagagcta gaaatagc 58
<210> 9
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
aaaagcaccg actcggtgcc 20
<210> 10
<211> 19
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
tttctcattc tccacctcc 19
<210> 11
<211> 18
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
acaaaataaa tcccagca 18
<210> 12
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
tcagagatgc ctttaaccgt c 21
<210> 13
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
gccagtgatt cagaagggct 20
<210> 14
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
tgaaaccgct gcccatattc 20
<210> 15
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
atggtgttcc agttcctcgt 20
<210> 16
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
ccgaatgatc cgtgttctgt g 21
<210> 17
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 17
gttgatggag acgcagtcgg 20
Claims (1)
1.epc1 -/- epc2 -/- Application of mutant zebra fish in construction of environment-susceptible zebra fish modelepc1 -/- epc2 -/- Mutant zebra fish is double-deleted in wild zebra fishepc1Andepc2the application process of the homozygote transgenic fish of the gene is respectively constructedepc1Andepc2the homozygous mutant zebra fish with single gene deletion is hybridized to obtain the homozygous double mutantepc1 -/- epc2 -/- Zebra fish; CRISPR/Cas9 gene editing technology adopted by constructing single-gene deletion homozygous mutant zebra fish,epc1the gRNA target sites were: 5'-ggtctggcagatcctcgcag-3' the number of the individual pieces of the plastic, epc2the gRNA target sites were: 5'-gggcgtctagcgctcgcgcg-3';
the said processepc1The gene ID of the gene is 566686,epc2gene ID of the gene 394050;
the environmental susceptibility is aeromonas hydrophila susceptibility or/and hypoxia stress susceptibility.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210261147.0A CN114703228B (en) | 2022-03-16 | 2022-03-16 | Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210261147.0A CN114703228B (en) | 2022-03-16 | 2022-03-16 | Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114703228A CN114703228A (en) | 2022-07-05 |
CN114703228B true CN114703228B (en) | 2024-03-05 |
Family
ID=82167928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210261147.0A Active CN114703228B (en) | 2022-03-16 | 2022-03-16 | Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114703228B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113416752A (en) * | 2021-06-23 | 2021-09-21 | 周娟 | Mog1 gene knockout zebra fish model and application |
CN115747222A (en) * | 2022-10-26 | 2023-03-07 | 华中农业大学 | Application of prdm15 gene in preparation of environment-sensitive mutant fish |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033986A1 (en) * | 1997-12-30 | 1999-07-08 | Chiron Corporation | MAMMALIAN ENHANCER OF POLYCOMB (epc) ACTS AS A TUMOR SUPPRESSOR |
-
2022
- 2022-03-16 CN CN202210261147.0A patent/CN114703228B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033986A1 (en) * | 1997-12-30 | 1999-07-08 | Chiron Corporation | MAMMALIAN ENHANCER OF POLYCOMB (epc) ACTS AS A TUMOR SUPPRESSOR |
Non-Patent Citations (4)
Title |
---|
斑马鱼在生态毒理学研究及环境监测中的应用;刘辉等;中国实验动物学报;第529页第2段-530页第1段、第532页右栏第2段、第533页左栏第1段 * |
斑马鱼实验动物化研究及应用;郑丽丽;吴端生;;南华大学学报(医学版)(第02期);第108-110页 * |
铜过载斑马鱼胚胎中肌细胞发育和epc1/2介导的造血细胞发育缺陷下的表观调控机制研究;刘文叶;中国优秀博士学位论文全文数据库农业科技辑;第45、62-63页 * |
鱼类好斗性分子调控机制的研究进展;徐秀文;张秀梅;;中国水产科学(第05期);第225-238页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114703228A (en) | 2022-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114703228B (en) | Application of epc1epc2 mutant in construction of environment-susceptible zebra fish model | |
CN109694915B (en) | Molecular marker related to sheep tail fat weight and application thereof | |
CN109694916B (en) | Molecular marker related to sheep feed conversion rate and application thereof | |
CN111850133B (en) | Low-temperature-resistant associated SNP molecular marker of litopenaeus vannamei, detection primer and application of detection primer | |
CN110791571B (en) | SNP marker for distinguishing Vibrio harveyi infection resistance of litopenaeus vannamei, and detection method and application thereof | |
CN110643716A (en) | Molecular marker related to sheep tail fat weight and application thereof | |
CN113930525B (en) | Specific sequence for snakehead sex identification and application | |
CN112226465B (en) | Application of isolated nucleotide sequence in construction of mineralizeless intermuscular bone zebra fish | |
CN108103108A (en) | Preparation and application of Cebpa gene-deleted zebra fish mutant | |
CN111394445A (en) | Indel marker for sex identification of channa maculata and application thereof | |
CN108676899A (en) | A kind of and the relevant SNP marker of Erhualian sow litter trait and its detection method | |
Su et al. | Efficiently whole-genomic mutagenesis approach by ARTP in blunt snout bream (Megalobrama amblycephala) | |
CN103233001B (en) | The detection method of Qinchuan Cattle FoxO1 gene mononucleotide polymorphism molecular marker and application | |
CN107858440B (en) | One kind SNP marker relevant to pig birth weight character and application thereof | |
CN113604587B (en) | Molecular marker T5198 for rapidly identifying low-temperature tolerant variety of penaeus japonicus and application thereof | |
CN115747347A (en) | SNP molecular marker related to Hu sheep horn type, amplification primer and kit, application of SNP molecular marker, amplification primer and kit, and method for judging Hu sheep horn type | |
CN112662677B (en) | Chironomus rubripes Hb gene and application thereof in water quality biological monitoring | |
CN112852980B (en) | Detection method for detecting nucleic acid of Atlantic salmon based on CRISPR fluorescence method and detection kit thereof | |
CN112029875B (en) | SNP (Single nucleotide polymorphism) marker related to growth of palaemon carinicauda, detection primer and application | |
CN113584188A (en) | Low-temperature-resistant molecular marker C6101 of penaeus japonicus and application | |
CN111363857A (en) | RPA primer, probe and kit for detecting TiLV of tilapia | |
CN105331610A (en) | Quintuple PCR primers for detecting pathogenic bacteria in fresh agricultural products, probe and detection kit | |
CN118374611B (en) | Molecular module related to oyster high temperature tolerance, detection primer and application | |
CN116004785B (en) | Molecular marker, primer group, kit and method for identifying gender of dace | |
CN116622717B (en) | Male sex differentiation control gene EcIAG and guide RNA of palaemon carinicauda and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |